Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 5/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | DRD4 | P21917 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | WDR5 | P61964 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11078704 | 0.89 | LMNA (0.42) | ACHETDP1CYP3A4TSHRTEAD4 | |
| SCHEMBL1727101 | 0.85 | ACHE (0.46) | ACHETDP1CYP3A4TSHRTEAD4 | |
| SCHEMBL130635 | 0.78 | ACHE (0.55) | ACHETDP1CYP3A4TSHRTEAD4 | |
| SCHEMBL7771299 | 0.76 | ACHE (0.52) | ACHETDP1CYP3A4TSHRTEAD4 | |
| SCHEMBL4809479 | 0.76 | ACHE (0.52) | ACHETDP1CYP3A4TSHRTEAD4 | |
| SCHEMBL8650801 | 0.76 | ACHE (0.52) | ACHETDP1CYP3A4TSHRTEAD4 | |
| SCHEMBL3729421 | 0.75 | MAPT (0.45) | TDP1TSHRALDH1A1POLBMAPT | |
| SCHEMBL28876309 | 0.75 | LMNA (0.42) | ACHETDP1CYP3A4TSHRTEAD4 | |
| SCHEMBL17189423 | 0.74 | CYP3A4 (0.43) | TDP1CYP3A4TSHRCA1CA2 | |
| SCHEMBL16641773 | 0.74 | ACHE (0.44) | ACHETDP1CYP3A4TSHRTEAD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8633127-B2 | Selective hydrogenation catalyst and methods of making and using same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2014-01-21 | — | — | US | claimed |
| US-20240002313-A1 | [11C]-LABELED ACYCLIC RETINOID, CENTRAL NERVOUS SYSTEM ACTIVATOR, AND PRODUCTION METHODS FOR SAME | NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY (JP) | 2024-01-04 | — | — | US | disclosed |
| EP-4249058-A1 | [11C]-LABELLED ACYCLIC RETINOID, CENTRAL NERVOUS SYSTEM ACTIVATOR, AND PRODUCTION METHODS FOR SAME | National Center for Geriatrics and Gerontology (JP) | 2023-09-27 | — | — | EP | disclosed |
| US-11274248-B2 | Lanthanoid-containing inorganic material microparticles, wavelength-converting ink, coated article, and determination apparatus | SEKISUI CHEMICAL CO., LTD. (JP) | 2022-03-15 | — | — | US | disclosed |
| EP-3144064-B1 | SELECTIVE HYDROGENATION CATALYST AND METHODS OF MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2021-07-28 | — | — | EP | disclosed |
| US-20210054271-A1 | LANTHANOID-CONTAINING INORGANIC MATERIAL MICROPARTICLES, WAVELENGTH-CONVERTING INK, COATED ARTICLE, AND DETERMINATION APPARATUS | SEKISUI CHEMICAL CO., LTD. (JP) | 2021-02-25 | — | — | US | disclosed |
| EP-3409748-B1 | LANTHANOID-CONTAINING INORGANIC MATERIAL MICROPARTICLES, WAVELENGTH-CONVERTING INK, COATED ARTICLE, AND DETERMINATION APPARATUS | SEKISUI CHEMICAL CO LTD (JP) | 2020-07-15 | — | — | EP | disclosed |
| EP-3409748-A1 | LANTHANOID-CONTAINING INORGANIC MATERIAL MICROPARTICLES, WAVELENGTH-CONVERTING INK, COATED ARTICLE, AND DETERMINATION APPARATUS | Sekisui Chemical Co., Ltd. (JP) | 2018-12-05 | — | — | EP | disclosed |
| EP-3377596-A1 | SELECTIVE HYDROGENATION USING A FLOW INDEX | Chevron Phillips Chemical Company LP (US) | 2018-09-26 | — | — | EP | disclosed |
| US-20180148260-A1 | Selective Hydrogenation Using a Flow Index | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2018-05-31 | — | — | US | disclosed |
| US-8373001-B2 | Method of producing dinitrile compounds | INVISTA NORTH AMERICA S.A R.L. (US) | 2013-02-12 | — | — | US | disclosed |
| EP-2403642-A2 | SELECTIVE HYDROGENATION CATALYST AND METHODS OF MAKING AND USING SAME | Chevron Phillips Chemical Company LP (US) | 2012-01-11 | — | — | EP | disclosed |
| WO-2010101736-A2 | SELECTIVE HYDROGENATION CATALYST AND METHODS OF MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2010-09-10 | — | — | WO | disclosed |
| US-20100228065-A1 | Selective Hydrogenation Catalyst and Methods of Making and Using Same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2010-09-09 | — | — | US | disclosed |
| EP-1592659-B1 | METHOD OF PRODUCING DINITRILE COMPOUNDS | INVISTA TECH SARL (CH) | 2009-07-22 | — | — | EP | disclosed |
| US-20060258873-A1 | Method of producing dinitrile compounds | RHODIA POLYAMIDE INTERMEDIATES (FR) | 2006-11-16 | — | — | US | disclosed |
| EP-1592659-A2 | METHOD OF PRODUCING DINITRILE COMPOUNDS | Rhodia Polyamide Intermediates (FR) | 2005-11-09 | — | — | EP | disclosed |
| WO-2004080924-A2 | METHOD OF PRODUCING DINITRILE COMPOUNDS | RHODIA POLYAMIDE INTERMEDIATES (FR) | 2004-09-23 | — | — | WO | disclosed |
| US-5600034-A | HEAT TREATING DIALLYL ETHERS IN PRESENCE OF CATALYST CONTAINING PALLADIUM AND PHOSPHORUS COMPOUNDS | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-02-04 | — | — | US | disclosed |
| US-5583271-A | Method for continuously producing alkadienols | MITSUBISHI CHEMICAL CORPORATION (JP) | 1996-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002313-A1 | [11C]-LABELED ACYCLIC RETINOID, CENTRAL NERVOUS SYSTEM ACTIVATOR, AND PRODUCTION METHODS FOR SAME | NR2E3, FABP7, RARB | ACHE 20/4885TDP1 3661/4885CYP3A4 2009/4885 |
| US-20060258873-A1 | Method of producing dinitrile compounds | NCL, DDC, NCLN | ACHE 195/4885TDP1 1823/4885CYP3A4 314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.